Advancements in the Treatment of Breast Cancer
Dr. Daniel Morganstern is Starling’s new leading breast cancer subspecialist. He is interviewed on Fox TV about a major research finding that was recently published from the largest breast oncology study to date. This study found that women with early stage, estrogen positive breast cancer that had not spread to lymph nodes may no longer benefit from chemotherapy. Hear about how this finding dramatically shapes treatment options for breast cancer patients as we enter a new era of personalized medicine.